Studied parameters | All patients | Responders | Nonresponders | P-value |
---|---|---|---|---|
(N = 44) | (n = 26) | (n = 18) | ||
MAP, mmHg | ||||
T0 | 71 (53 to 100) | 73 (55 to 100) | 70 (58 to 89) | 0.685 |
T1 | 78 (58 to 100) | 77 (68 to 102) | 79 (56 to 92) | 0.563 |
HR, beats/min | ||||
T0 | 106 (68 to 141) | 107 (75 to 138) | 101 (61 to 142) | 0.99 |
T1 | 101 (63 to 146) | 102 (70 to 147) | 101(61 to 142) | 0.738 |
CVP, mmHg | ||||
T0 | 10 (4 to 17) | 10 (5 to 17) | 8 (3 to 18) | 0.326 |
T1 | 101 (63 to 146) | 102 (70 to 147) | 101(61 to 142) | 0.738 |
LVFAC, % | ||||
T0 | 46 (21 to 61) | 50 (21 to 59) | 42 (21 to 62) | 0.75 |
T1 | 47 (23 to 63) | 47 (25 to 63) | 48 (26 to 61) | 0.861 |
AoVTI, cm | ||||
T0 | 13.7 (8.2 to 22.8) | 13.0 (8.3 to 19.9) | 15.6 (10.2 to 24.1) | 0.06 |
T1 | 18.0 (12.0 to 23.3) | 18.2 (12.0 to 23.0) | 16.9 (11.2 to 23.5) | 0.527 |
CI, L . min-1 - m-2 | ||||
T0 | 2.3 (1.3 to 3.8) | 2.3 (1.3 to 3.4) | 2.4 (1.2 to 4.0) | 0.841 |
T1 | 2.8 (1.5 to 4.3) | 3.1 (1.6 to 4.8) | 2.5 (1.4 to 3.2) | 0.054 |
DmaxSVC, mm | ||||
T0 | 13.2 (8.2 to 20.4) | 12.0 (8.3 to 19.8) | 14.0 (9.2 to 22.6) | 0.05 |
T1 | 14.6 (8.9 to 21.7) | 13.5 (8.5 to 22.4) | 15.0 (10.4 to 19.1) | 0.568 |
ΔSVC, % | ||||
T0 | 20 (6 to 47) | 31 (7 to 49) | 16 (5 to 30) | 0.01 |
T1 | 12 (3 to 63) | 15 (4 to 68) | 6 (0 to 25) | 0.008 |
DmaxIVC, mm | ||||
T0 | 19.6 (12.0 to 23.1) | 19.0 (12.0 to 28.9) | 19.9 (11.1 to 24.9) | 0.67 |
T1 | 21.1 (12.9 to 28.0) | 19.6 (12.1 to 28.1) | 22.2 (16.1 to 25.1) | 0.218 |
ΔIVC, % | ||||
T0 | 18 (2 to 55) | 12 (2 to 55) | 20 (3 to 58) | 0.453 |
T1 | 9 (2 to 26) | 10 (0 to 30) | 6 (3 to 25) | 0.47 |